Insulin-like growth factor-I (IGF-I) has mitogenic and antiapoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of breast cancer in premenopausal women. The actions
Serum insulin-like growth factor-I and breast cancer
β Scribed by Paolo Toniolo; Peter F. Bruning; Arslan Akhmedkhanov; Johannes M.G. Bonfrer; Karen L. Koenig; Annekatrin Lukanova; Roy E. Shore; Anne Zeleniuch-Jacquotte
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 57 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Insulin-like growth factors (IGFs) are potent mitogens involved in the regulation of cell proliferation and apoptosis. The action of IGFs is mediated through a specific cell membrane receptor (IGF-IR), and the interactions between IGFs and this receptor are regulated by IGF-binding proteins (IGFBPs)
In this study we asked whether their normal size relationships were preserved in the growth hormone (GH) and one of its key mediators, transgenic mice. In addition, spinal cord and brain insulin-like growth factor I (IGF-I), influence spinal weights were significantly increased in both types of moto
Haemangiopericytoma is a rare soft tissue tumour originating from the contractile pericapillary cells. Relatively little is known about its molecular pathogenesis. To address this issue, the insulin-like growth factor family (IGFs) was analysed in 19 tumours collected from a human tumour bank networ
Insulin-like growth factor-I (IGF-I) is known as a potent mitogen for a variety of cell types, including colon cancer cell lines. The objective of this study was to determine the effect of IGF-I on cell death induced by cytotoxic agents actinomycin D (Act-D), lovastatin (LOV), and doxorubicin (DOX)